Search Results - "Imakita, Takuma"

Pulmonary Lymphangitis Carcinomatosa Mimicking Immunotherapy-Related Interstitial Pneumonitis: A Case Report by Imakita, Takuma, Fujita, Kohei, Kanai, Osamu, Mio, Tadashi

“…Abstract While immunotherapy with immune checkpoint inhibitors has achieved promising effects in advanced lung cancer treatment, it can induce some unique…”
Get full text

Single-centre observational study of the safety and efficacy of thoracoscopy under local anaesthesia for the management of thoracic infections by Fujita, Kohei, Saito, Zentaro, Ito, Takanori, Imakita, Takuma, Oi, Issei, Kanai, Osamu, Yamamoto, Yuki, Hata, Hiroaki, Sawai, Satoru, Tanizawa, Kiminobu

“…Thoracoscopy under local anaesthesia is widely performed to diagnose malignancies and infectious diseases. However, few reports have described the use of this…”
Get full text

Impact on prognosis of rebiopsy in advanced non-small cell lung cancer patients after epidermal growth factor receptor-tyrosine kinase inhibitor treatment: a systematic review by Imakita, Takuma, Matsumoto, Hirotaka, Hirano, Katsuya, Morisawa, Toshiyuki, Sakurai, Azusa, Kataoka, Yuki

“…Osimertinib, the third-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), has become the standard treatment in cases where…”
Get full text

Safety of flexible bronchoscopy and clinical course for elderly patients with suspected primary lung cancer by Saito, Zentaro, Oi, Issei, Ito, Takanori, Imakita, Takuma, Kanai, Osamu, Fujita, Kohei, Mio, Tadashi

“…Background There have been several reports demonstrating the safety of flexible bronchoscopy (FB) in the elderly, but none have focused specifically on lung…”
Get full text

Organizing pneumonia secondary to pulmonary cryptococcosis in immunocompromised patient by Saito, Zentaro, Ito, Takanori, Imakita, Takuma, Oi, Issei, Kanai, Osamu, Fujita, Kohei

“…Pulmonary cryptococcal infections are fungal infections that often occur in immunocompromised patients and present with a variety of radiographic patterns…”
Get full text

Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study by Fujita, Kohei, Ito, Yutaka, Yamamoto, Yuki, Kanai, Osamu, Imakita, Takuma, Oi, Issei, Ito, Takanori, Saito, Zentaro, Mio, Tadashi

“…Abstract Background The incidence of nontuberculous mycobacterial lung disease (NTM-LD) peaks in middle- and old age groups, coinciding with senescence; thus,…”
Get full text

Primary Pulmonary Malignant Melanoma Successfully Treated with Immunotherapy in a 90-Year-Old Patient by Fujita, Kohei, Nakatani, Koichi, Imakita, Takuma, Kanai, Osamu, Mio, Tadashi

“…Malignant melanoma is a rare and high-grade cancer. It most commonly affects the skin, but it has the potential to involve all areas of the body. Primary…”
Get full text

Small cell transformation of non‐small cell lung cancer under immunotherapy: Case series and literature review by Imakita, Takuma, Fujita, Kohei, Kanai, Osamu, Okamura, Misato, Hashimoto, Masayuki, Nakatani, Koichi, Sawai, Satoru, Mio, Tadashi

“…In advanced lung cancer treatment, immunotherapy provides durable responses in some patients. However, other patients experience progressive disease and the…”
Get full text

Kristen rat sarcoma virus (KRAS) G12F‐positive non‐small cell lung cancer mimicking KRAS G12C positivity: A case report by Oi, Issei, Ito, Takanori, Saito, Zentaro, Imakita, Takuma, Kanai, Osamu, Fujita, Kohei, Tachibana, Hiromasa, Mio, Tadashi

“…Searching for driver gene alteration is a prerequisite for chemotherapy of non‐small cell lung cancer. Due to its high sensitivity and concordance rate, the…”
Get full text

Small cell lung cancer transformation during immunotherapy with nivolumab: A case report by Imakita, Takuma, Fujita, Kohei, M.D, Ph.D, Kanai, Osamu, Terashima, Tsuyoshi, Mio, Tadashi

“…Abstract We report a rare case of transformation of non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC), without epidermal growth factor…”
Get full text

Successful Rechallenge with Osimertinib following Osimertinib-Induced Ventricular Tachycardia: A Case Report by Saito, Zentaro, Imakita, Takuma, Ito, Takanori, Oi, Issei, Kanai, Osamu, Fujita, Kohei, Tachibana, Hiromasa, Mio, Tadashi

“…Abstract Osimertinib, a third-generation tyrosine kinase inhibitor, is the first-line treatment for metastatic non-small cell lung cancer (NSCLC) with…”
Get full text

Natural course of pulmonary hyalinizing granuloma over a decade by Fujita, Kohei, Okamura, Misato, Imakita, Takuma, Yamamoto, Yuki, Sawai, Satoru, Moriyoshi, Koki, Mio, Tadashi

“…Pulmonary hyalinizing granuloma (PHG) is a very rare pulmonary disease characterized by multiple fibrosclerotic inflammatory lung nodules. The disease is…”
Get full text

Re-immunotherapy with nivolumab plus ipilimumab in advanced non-small cell lung cancer patients previously treated with anti-programmed death-1 and/or anti-programmed death ligand-1 antibodies by Imakita, Takuma, Fujita, Kohei, Ito, Takanori, Saito, Zentaro, Oi, Issei, Kanai, Osamu, Tachibana, Hiromasa, Sawai, Satoru, Mio, Tadashi

“…Background The role of re-immunotherapy in advanced non-small cell lung cancer (NSCLC) remains unclear. No studies have evaluated the re-immunotherapy regimen…”
Get full text

Pegfilgrastim-Induced Aortitis in a Patient with Small-Cell Lung Cancer Who Received Immunotherapy Combined with Chemotherapy by Ito, Takanori, Kanai, Osamu, Saito, Zentaro, Imakita, Takuma, Oi, Issei, Fujita, Kohei, Tachibana, Hiromasa, Mio, Tadashi

“…Abstract Introduction: Granulocyte colony-stimulating factor (G-CSF), including pegfilgrastim, increases the peripheral blood leukocyte count and is widely…”
Get full text

Safety and Efficacy of Flexible Bronchoscopy in Elderly Patients: A Retrospective Comparative Study by Saito, Zentaro, Oi, Issei, Ito, Takanori, Imakita, Takuma, Kanai, Osamu, Fujita, Kohei, Tachibana, Hiromasa, Mio, Tadashi

“…[Display omitted] Flexible bronchoscopy (FB) is a common method used for diagnostic sampling of the thorax. Although the safety and efficacy of FB in the…”
Get full text

A 92‐year‐old patient with thoracic empyema successfully treated by CT‐guided insertion of a pigtail catheter by Fujita, Kohei, Hirai, Masataka, Saito, Zentaro, Ito, Takanori, Imakita, Takuma, Oi, Issei, Kanai, Osamu, Tachibana, Hiromasa, Mio, Tadashi

“…We present a case report of a 92‐year‐old patient with thoracic empyema, who was successfully treated via CT‐guided insertion of a pigtail catheter. The…”
Get full text

Rare case of de novo EGFR L718V mutation-positive non-small cell lung cancer successfully treated with afatinib by Ito, Takanori, Fujita, Kohei, Saito, Zentaro, Imakita, Takuma, Oi, Issei, Kanai, Osamu, Tachibana, Hiromasa, Mio, Tadashi

“…Since the FLAURA trial, epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC) has generally been treated with…”
Get full text

Simultaneous regression of non‐small cell lung cancer and orbital extranodal marginal zone lymphoma with chemoradiotherapy for lung cancer by Oi, Issei, Saito, Zentaro, Ito, Takanori, Imakita, Takuma, Kanai, Osamu, Fujita, Kohei, Tachibana, Hiromasa, Mori, Minako, Morioshi, Koki, Mio, Tadashi

“…This report describes the case of a 79‐year‐old Japanese man diagnosed with orbital extranodal marginal zone lymphoma (EMZL) and stage IIIA lung cancer. The…”
Get full text

De Novo SCLC Transformation From KRAS G12C-Mutated Lung Adenocarcinoma With Excellent Response to Sotorasib: A Case Report by Ito, Takanori, Oi, Issei, Saito, Zentaro, Imakita, Takuma, Kanai, Osamu, Fujita, Kohei, Tachibana, Hiromasa, Moriyoshi, Koki, Mio, Tadashi

“…The transformation to SCLC is a known mechanism of resistance against molecularly targeted therapies. This study reports a patient with untreated lung…”
Get full text

Serial interferon-gamma release assay in lung cancer patients receiving immune checkpoint inhibitors: a prospective cohort study by Fujita, Kohei, Elkington, Paul, Redelman-Sidi, Gil, Kanai, Osamu, Yamamoto, Yuki, Imakita, Takuma, Okamura, Misato, Nakatani, Koichi, Mio, Tadashi

“…Recent advancements in cancer immunotherapy using immune checkpoint inhibitors (ICIs) have received considerable attention. Although advantageous, ICI…”
Get full text